Skip to main content
hpa logo
Topics A-Z:
Search the site:

Characteristics of MRSA identified in the UK

In commonly occurring lineages, DNA sequencing of the spa gene allows presumptive identification of Healthcare- and Community-Associated MRSA strains identified in the UK and MLST clonal complex designation.

 

Characteristics of MRSA identified in the UK

Description

Common names

PVL status

MLST clonal complex (ST)

Typical spa type

spa repeat succession

Healthcare-Associated MRSA (HA-MRSA)

UK EMRSA-1, -4, -7, -9, -11; Brazilian/Hungarian clone

Negative

8 (239 or 240)

t037

15-12-16-02-25-17-24

 

UK EMRSA-2, -6, -12, -13, -14; Irish-1; Irish-2

Negative

8 (8)

t190

11-17-34-24-34-22-25

 

UK EMRSA-5, -17; Iberian clone

Negative

8(247)

t051

11-19-21-12-21-17-34-24-34-22-25

 

UK EMRSA-3

Negative

5 (5)

t001

26-30-17-34-17-20-17-12-17-16

 

UK EMRSA-8

Negative

8 (250)

t194

11-19-12-12-12-34-34-24-34-22-25

 

UK EMRSA-10

Negative

8 (254)

t009

11-12-21-17-34-24-34-22-24-34-22-33-25

 

UK EMRSA-15

Negative

22 (22)

t032

26-23-23-13-23-31-29-17-31-29-17-25-17-25-16-28

 

UK EMRSA-16

Negative

30 (36)

t018

15-12-16-02-16-02-25-17-24-24-24

Community-Associated MRSA (CA-MRSA)

USA 400

Positive

1 (1)

t128

07-23-23-21-16-34-33-13

 

Bengal Bay clone

Positive

1 (ST772)

t657

26-23-13-21-17-34-33-34

 

CC5

Positive

5 (5)

t002

26-23-17-34-17-20-17-12-17-16

 

USA 300

Positive

8 (8)

t008

11-19-12-21-17-34-24-34-22-25

 

CC22

Positive

22 (22)

t005

26-23-13-23-31-05-17-25-17-25-16-28

 

South-West Pacific clone

Positive

30 (30)

t019

08-16-02-16-02-25-17-24

 

South-East Asia clone

Positive

59 (59)

t437

04-20-17-20-17-25-34

 

European clone

Positive

80 (80)

t044

07-23-12-34-34-33-34

 

CC88

Positive

88 (88)

t690

07-12-21-17-13-13-34-34-34-33-34

 

Queensland clone

Positive

93 (93)

t202

11-17-23-17-17-16-16-25

PVL: Panton-Valentine Leukocidin

MLST = Multi-Locus Sequence Type
ST: sequence type

CC: MLST clonal complex


Last reviewed: 14 October 2010



© Health Protection Agency 2012